1. Home
  2. NAUT vs CDLX Comparison

NAUT vs CDLX Comparison

Compare NAUT & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAUT
  • CDLX
  • Stock Information
  • Founded
  • NAUT 2016
  • CDLX 2008
  • Country
  • NAUT United States
  • CDLX United States
  • Employees
  • NAUT N/A
  • CDLX N/A
  • Industry
  • NAUT Biotechnology: Laboratory Analytical Instruments
  • CDLX Computer Software: Programming Data Processing
  • Sector
  • NAUT Industrials
  • CDLX Technology
  • Exchange
  • NAUT Nasdaq
  • CDLX Nasdaq
  • Market Cap
  • NAUT 95.6M
  • CDLX 93.5M
  • IPO Year
  • NAUT N/A
  • CDLX 2018
  • Fundamental
  • Price
  • NAUT $0.70
  • CDLX $1.11
  • Analyst Decision
  • NAUT Strong Sell
  • CDLX Hold
  • Analyst Count
  • NAUT 1
  • CDLX 5
  • Target Price
  • NAUT $1.75
  • CDLX $3.25
  • AVG Volume (30 Days)
  • NAUT 203.3K
  • CDLX 1.4M
  • Earning Date
  • NAUT 07-31-2025
  • CDLX 08-06-2025
  • Dividend Yield
  • NAUT N/A
  • CDLX N/A
  • EPS Growth
  • NAUT N/A
  • CDLX N/A
  • EPS
  • NAUT N/A
  • CDLX N/A
  • Revenue
  • NAUT N/A
  • CDLX $266,201,000.00
  • Revenue This Year
  • NAUT N/A
  • CDLX N/A
  • Revenue Next Year
  • NAUT N/A
  • CDLX $5.51
  • P/E Ratio
  • NAUT N/A
  • CDLX N/A
  • Revenue Growth
  • NAUT N/A
  • CDLX N/A
  • 52 Week Low
  • NAUT $0.66
  • CDLX $0.95
  • 52 Week High
  • NAUT $3.09
  • CDLX $5.25
  • Technical
  • Relative Strength Index (RSI)
  • NAUT 44.44
  • CDLX 36.47
  • Support Level
  • NAUT $0.67
  • CDLX $0.95
  • Resistance Level
  • NAUT $0.76
  • CDLX $1.32
  • Average True Range (ATR)
  • NAUT 0.04
  • CDLX 0.14
  • MACD
  • NAUT -0.00
  • CDLX -0.04
  • Stochastic Oscillator
  • NAUT 29.29
  • CDLX 15.69

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Share on Social Networks: